_PRIVATE_LIMITED.webp)
Healthplan Pharma ( India) Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 10-01-2025
- Paid Up Capital ₹ 3.91 M
as on 10-01-2025
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 7.23 M
as on 10-01-2025
- Satisfied Charges ₹ 0.54 M
as on 10-01-2025
- Revenue -12.06%
(FY 2019)
- Profit -12.23%
(FY 2019)
- Ebitda -20.15%
(FY 2019)
- Net Worth 15.04%
(FY 2019)
- Total Assets 5.71%
(FY 2019)
About Healthplan Pharma ( India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 3.91 M.
The company currently has active open charges totaling ₹7.23 M. The company has closed loans amounting to ₹0.54 M, as per Ministry of Corporate Affairs (MCA) records.
Narendra Anand and Shweta Anand serve as directors at the Company.
- CIN/LLPIN
U24233DL2008PTC181369
- Company No.
181369
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 2008
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Healthplan Pharma ( India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Anand  | Director | 25-Jul-2008 | Current |
| Shweta Anand | Director | 04-Apr-2009 | Current |
Financial Performance of Healthplan Pharma ( India).
Healthplan Pharma ( India) Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 12.06% decrease. The company also saw a substantial fall in profitability, with a 12.23% decrease in profit. The company's net worth Soared by an impressive increase of 15.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healthplan Pharma ( India)?
In 2019, Healthplan Pharma ( India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jun 2017 | ₹2.49 M | Open |
Hdfc Bank Limited Creation Date: 16 Oct 2014 | ₹0.85 M | Open |
Corporation Bank Creation Date: 30 Jul 2014 | ₹0.79 M | Open |
How Many Employees Work at Healthplan Pharma ( India)?
Unlock and access historical data on people associated with Healthplan Pharma ( India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healthplan Pharma ( India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healthplan Pharma ( India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
